skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: HighWire Press (Free Journals) remover assunto: Middle Aged remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Loss of Glomerular Permselectivity in Type 2 Diabetes Associates With Progression to Kidney Failure
Loss of Glomerular Permselectivity in Type 2 Diabetes Associates With Progression to Kidney Failure
Material Type:
Artigo 		Adicionar ao Meu Espaço

Loss of Glomerular Permselectivity in Type 2 Diabetes Associates With Progression to Kidney Failure

Saulnier, Pierre J ; Looker, Helen C ; Layton, Anita ; Lemley, Kevin V ; Nelson, Robert G ; Bjornstad, Petter

Diabetes (New York, N.Y.), 2023-11, Vol.72 (11), p.1682-1691 [Periódico revisado por pares]

United States: American Diabetes Association

Texto completo disponível

Citações Citado por
2
Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes
Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes

Saulnier, Pierre-Jean ; Wheelock, Kevin M ; Howell, Scott ; Weil, E Jennifer ; Tanamas, Stephanie K ; Knowler, William C ; Lemley, Kevin V ; Mauer, Michael ; Yee, Berne ; Nelson, Robert G ; Beisswenger, Paul J

Diabetes (New York, N.Y.), 2016-12, Vol.65 (12), p.3744-3753 [Periódico revisado por pares]

United States: American Diabetes Association

Texto completo disponível

Citações Citado por
3
Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis
Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis

Lanternier, F ; Poiree, S ; Elie, C ; Garcia-Hermoso, D ; Bakouboula, P ; Sitbon, K ; Herbrecht, R ; Wolff, M ; Ribaud, P ; Lortholary, O

Journal of antimicrobial chemotherapy, 2015-11, Vol.70 (11), p.3116-3123 [Periódico revisado por pares]

England: Oxford Publishing Limited (England)

Texto completo disponível

Citações Citado por
4
Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3
Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3

BORGET, I ; CADRANEL, J ; DANIEL, C ; MORIN, F ; CHOUAID, C ; PIGNON, J.-P ; QUOIX, E ; COUDERT, B ; WESTEEL, V ; DANSIN, E ; MADELAINE, J ; MADROSZYK, A ; FRIARD, S

The European respiratory journal, 2012-01, Vol.39 (1), p.172-179 [Periódico revisado por pares]

Leeds: Maney

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.